Brief: Biomerieux Gets U.S. FDA Clearance For New Version Of BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid

Biomerieux SA

11/02/2025 06:53

Feb 11 (Reuters) - Biomerieux SA  BIOX.PA :
    * ANNOUNCED ON TUESDAY IT RECEIVED U.S. FDA CLEARANCE FOR
NEW
VERSION OF MOLECULAR TEST TARGETING CAUSES OF GASTROENTERITIS,
BIOFIRE® FILMARRAY® GASTROINTESTINAL (GI) PANEL MID
    * BIOFIRE® GASTROINTESTINAL (GI) PANEL MID TO BE
COMMERCIALLY
AVAILABLE IN U.S. AT END OF H1 2025

        
 Source text: https://tinyurl.com/4vv6xxfd
 Further company coverage:  BIOX.PA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))